Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants

BACKGROUND: There is a lack of data on anticoagulation requirements during ablation of atrial fibrillation (AF). This study compares different oral anticoagulation (OAC) strategies to evaluate risk of bleeding and thromboembolic complications. METHODS: We conducted a single-centre study in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkmeier-Theofanopoulou, Maria, Tzamalis, Panagiotis, Wehrkamp-Richter, Susan, Radzewitz, Andrea, Merkel, Matthias, Schymik, Gerhard, van Mark, Gesine, Bramlage, Peter, Schmitt, Claus, Luik, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924498/
https://www.ncbi.nlm.nih.gov/pubmed/29703158
http://dx.doi.org/10.1186/s12872-018-0804-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924498/
https://www.ncbi.nlm.nih.gov/pubmed/29703158
http://dx.doi.org/10.1186/s12872-018-0804-6

Ejemplares similares